Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 29, 2008
Cost impact of diagnostic imaging for lower extremity peripheral vascular occlusive disease
Joel W Hay, Elizabeth Lawler, Kent Yucel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2010
Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries
Stuart L Goldberg, Er Chen, Mitra Corral, et al.
Contraception
|
August 15, 2006
Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception
Paul D Blumenthal, James Trussell, Rameet H Singh, et al.
Microcirculation (New York, N.Y. : 1994)
|
May 14, 2026
Capillary Density and Neuronal Homeostasis in Human Primary Visual Cortex
Yi-Chung Wang, Amy Guo, Adam J H Newton, et al.
Anaerobe
|
October 20, 2025
Microbiome and metabolome changes after fecal microbiota, live-jslm, administration are associated with health-related quality of life improvements
Rohan Mishra, Adam Harvey, Amy Guo, et al.
Infectious Diseases and Therapy
|
March 22, 2025
Characteristics and Real-World Outcomes of Patients Treated with Fecal Microbiota, Live-jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Sanghyuk Seo, Min Yang, et al.
Pain Physician
|
October 1, 2024
Treatment Gaps and Emerging Therapies in Lumbar Disc Herniation
Douglas P Beall, Kee D Kim, Kevin Macadaeg, et al.
Journal of Women'S Health (2002)
|
March 11, 2008
Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool
Gene V Wallenstein, Bonnie Blaisdell-Gross, Kavita Gajria, et al.
Journal of Medical Economics
|
May 17, 2012
The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Annie Guérin, Eric Q Wu, Vamsi K Bollu, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 28, 2011
Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases
Jipan Xie, Madhav Namjoshi, Eric Q Wu, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 29, 2008
Cost impact of diagnostic imaging for lower extremity peripheral vascular occlusive disease
Joel W Hay, Elizabeth Lawler, Kent Yucel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2010
Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries
Stuart L Goldberg, Er Chen, Mitra Corral, et al.
Contraception
|
August 15, 2006
Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception
Paul D Blumenthal, James Trussell, Rameet H Singh, et al.
Microcirculation (New York, N.Y. : 1994)
|
May 14, 2026
Capillary Density and Neuronal Homeostasis in Human Primary Visual Cortex
Yi-Chung Wang, Amy Guo, Adam J H Newton, et al.
Anaerobe
|
October 20, 2025
Microbiome and metabolome changes after fecal microbiota, live-jslm, administration are associated with health-related quality of life improvements
Rohan Mishra, Adam Harvey, Amy Guo, et al.
Infectious Diseases and Therapy
|
March 22, 2025
Characteristics and Real-World Outcomes of Patients Treated with Fecal Microbiota, Live-jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Sanghyuk Seo, Min Yang, et al.
Pain Physician
|
October 1, 2024
Treatment Gaps and Emerging Therapies in Lumbar Disc Herniation
Douglas P Beall, Kee D Kim, Kevin Macadaeg, et al.
Journal of Women'S Health (2002)
|
March 11, 2008
Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool
Gene V Wallenstein, Bonnie Blaisdell-Gross, Kavita Gajria, et al.
Journal of Medical Economics
|
May 17, 2012
The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Annie Guérin, Eric Q Wu, Vamsi K Bollu, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 28, 2011
Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases
Jipan Xie, Madhav Namjoshi, Eric Q Wu, et al.
Page
of 7